Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | nitroreductase | 0.0629 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Giardia lamblia | Nitroreductase family protein | 0.0055 | 0 | 0.5 |
Trypanosoma brucei | nitroreductase | 0.0629 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved protein Acg | 0.0055 | 0 | 0.5 |
Mycobacterium tuberculosis | Putative oxidoreductase | 0.0055 | 0 | 0.5 |
Mycobacterium ulcerans | nitroreductase | 0.0055 | 0 | 0.5 |
Giardia lamblia | Nitroreductase Fd-NR2 | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Mycobacterium ulcerans | oxidoreductase | 0.0055 | 0 | 0.5 |
Mycobacterium ulcerans | F420-0--gamma-glutamyl ligase | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable F420 biosynthesis protein FbiB | 0.0055 | 0 | 0.5 |
Mycobacterium ulcerans | nitroreductase | 0.0055 | 0 | 0.5 |
Mycobacterium leprae | Possible oxidoreductase | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Mycobacterium leprae | Probable F420 biosynthesis protein FbiB | 0.0055 | 0 | 0.5 |
Trypanosoma cruzi | nitroreductase | 0.0629 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Entamoeba histolytica | nitroreductase family protein | 0.0055 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0055 | 0 | 0.5 |
Giardia lamblia | Nitroreductase family protein fused to ferredoxin domain Fd-NR1 | 0.0055 | 0 | 0.5 |
Mycobacterium ulcerans | nitroreductase | 0.0055 | 0 | 0.5 |
Entamoeba histolytica | nitroreductase family protein | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.0055 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0055 | 0 | 0.5 |
Onchocerca volvulus | Iodotyrosine dehalogenase 1 homolog | 0.0055 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0 | 0.5 |
Brugia malayi | nitroreductase family protein | 0.0055 | 0 | 0.5 |
Mycobacterium ulcerans | nitroreductase | 0.0055 | 0 | 0.5 |
Mycobacterium ulcerans | hypothetical protein | 0.0055 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0055 | 0 | 0.5 |
Entamoeba histolytica | nitroreductase family protein | 0.0055 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Decrease (functional) | = 12 % | Vasorelaxant activity determined by percentage inhibition of calcium-induced contraction on K+ depolarized guinea pig aortic strip at 5x10E-5 M | ChEMBL. | 15801835 |
Decrease (functional) | = 18 % | Negative chronotropic activity was determined as percent decrease in the artial rate in spontaneously beating guinea pig artium at 5x10E-5 M (n=6-8) | ChEMBL. | 15801835 |
Decrease (functional) | = 97 % | Negative inotropic activity of the compound was determined as decrease in the developed tension in isolated guinea pig left artium at 5x10E-5 M (n=4-6) | ChEMBL. | 15801835 |
EC50 (functional) | = 0.32 uM | Negative inotropic potency of the compound was determined as decrease in the developed tension in isolated guinea pig left artium | ChEMBL. | 15801835 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.